Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03806296 · ClinicalTrials.gov registry record · NA
Delayed Sleep Timing in Teens Study
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 142
- Enrollment target
NCT03806296 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 142 participants.
The verdict
NCT03806296, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
Study Summary
This study will (1) comprehensively characterize the substance use disorder (SUD) risk profile associated with adolescent Delayed Sleep Phase (DSP), and (2) probe whether SUD risk is diminished by altering sleep/circadian timing.
Interventions
- OTHER Increase morning bright light
- OTHER Decrease evening blue light
- BEHAVIORAL Monitor sleep, mood, and substance use
- BEHAVIORAL Sleep scheduling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2018-12-03 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03806296
The ClinicalTrials.gov registry entry for NCT03806296 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Increase morning bright light is the first listed.
NCT03806296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03806296 about?
NCT03806296 is a clinical study titled "Delayed Sleep Timing in Teens Study". This study will (1) comprehensively characterize the substance use disorder (SUD) risk profile associated with adolescent Delayed Sleep Phase (DSP), and (2) probe whether SUD risk is diminished by altering sleep/circadian timing.
What is the current status of trial NCT03806296?
This trial is currently completed. It is a NA study. The enrollment target is 142 participants. The study started on 2018-12-03. Estimated completion is 2024-11-30.
What interventions are being tested in trial NCT03806296?
The interventions under investigation include: Increase morning bright light (OTHER), Decrease evening blue light (OTHER), Monitor sleep, mood, and substance use (BEHAVIORAL), Sleep scheduling (BEHAVIORAL).
Who is sponsoring clinical trial NCT03806296?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.